By Kate Kelland LONDON, July 3 (Reuters) - Scientists conducting a major trial of a therapy that replaces the faulty gene responsible for cystic fibrosis say the treatment has showed significant benefit for the first time in patients' lung function. The technique, developed with the t
Read moreAIM listed firms Imperial Innovations and Mercia Technologies have together provided £4m to aluminium business Impression Technologies. The duo invested £2.5m and £1.5m respectively in the firm which makes aluminium components for the transport sector. The investment brings Imperial Innovation's s
Read moreBritish technology transfer and commercialisation company Imperial Innovations Group said it has invested £3m in portfolio company Abingdon Health. On Tuesday, the London-listed group said that, along with existing investors, it had invested £2.5m in Abingdon and now holds a 33.7% stake in the busin
Read moreLONDON, June 25 (Reuters) - Banks, investors and big drug companies should consider creating a 10-billion-pound ($15.7 billion) "megafund" to help biotech firms in London and across Britain compete with U.S. rivals, London mayor Boris Johnson said on Thursday. Britain is a leader in academi
Read moreTechnology investment group Imperial Innovations Group has appointed Paolo Paoletti as executive chairman of its portfolio company Kesios Therapeutics. London-based Kesios, which develops novel therapeutics for cancer treatments, was created to develop and commercialise certain research from the Dep
Read more